Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Account Payables: 2022-2025

Historic Change in Account Payables for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$795,000.

  • Gossamer Bio's Change in Account Payables fell 169.49% to -$795,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 847.05%. This contributed to the annual value of -$1.7 million for FY2024, which is 141.50% down from last year.
  • As of Q3 2025, Gossamer Bio's Change in Account Payables stood at -$795,000, which was up 86.38% from -$5.8 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Change in Account Payables peaked at $4.3 million during Q4 2023, and registered a low of -$5.8 million during Q2 2025.
  • In the last 3 years, Gossamer Bio's Change in Account Payables had a median value of -$795,000 in 2025 and averaged -$475,909.
  • Its Change in Account Payables has fluctuated over the past 5 years, first surged by 1,395.44% in 2023, then crashed by 339.08% in 2024.
  • Over the past 4 years, Gossamer Bio's Change in Account Payables (Quarterly) stood at $285,000 in 2022, then soared by 1,395.44% to $4.3 million in 2023, then fell by 27.73% to $3.1 million in 2024, then tumbled by 169.49% to -$795,000 in 2025.
  • Its Change in Account Payables stands at -$795,000 for Q3 2025, versus -$5.8 million for Q2 2025 and -$937,000 for Q1 2025.